GILEAD SCIENCES, INC. — Director's Dealing 2016

May 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-05-11

Reporting Person: WILSON GAYLE E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-11	Restricted Stock Unit	$	A	1787	Acquired		Common Stock (1787)	Direct
2016-05-11	Non-qualified Stock Option (Right to Buy)	$83.90	A	7321	Acquired	2026-05-11	Common Stock (7321)	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2: 100% of the restricted stock units will vest upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.

F3: Options vest quarterly over the first year of service upon the earlier of May 11, 2017, or the day immediately preceding the next regular annual stockholders meeting.